Patrick Wilson was only 18 years old when he received his cancer diagnosis. Just like any other teen his age, he was in school, loved sports and looked forward to the future when his world drastically changed.
“I knew something was up, but I didn’t know what. I will never be able to replicate that feeling of being in the hospital and being told it looks like a large tumour,” Wilson told Global News.
He said he felt “shocked and scared” and knew nothing about cancer at the time. And then came the chemotherapy and radiation.
It was March 2016 when the teen received the fateful news. Doctors diagnosed Wilson with Stage 4 embryonal rhabdomyosarcoma – or RMS, which had a 20 to 50 per cent chance of survival.
Embryonal rhabdomyosarcoma is a malignant soft tissue tumour that’s formed from embryonic skeletal muscle tissue. In most cases, it’s a quickly growing tumour that causes noticeable symptoms.
Rare sarcomas, like Wilson’s diagnosis, are incredibly infrequent. Sarcomas represent less than one per cent of adult malignancies, and from this one per cent, there are more than 50 subtypes, according to Dr. Abha Gupta, an oncologist at Princess Margaret.
Read more at http://globalnews.ca